Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999091 | Surgical Oncology Clinics of North America | 2008 | 18 Pages |
Abstract
The discovery of 25,000 human genes from the Human Genome Project has had a dramatic impact on the translational landscape of human diseases. Nowhere is the impact more apparent than in the field of cancer, specifically breast cancer. Understanding of the malignant process at a molecular level, coupled with the discovery of novel molecular techniques, has shifted the paradigm of treating breast cancer from a clinical, population-based risk assessment model to one based on molecular classification of disease.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Quyen D. Chu, Neal Holm, Kerry Byrnes, Benjamin D. Li,